Full text is available at the source.
Abstract
Psilocybin microdosing may influence molecular mechanisms related to affective and anxiety disorders.
- Repeated administration of sub-perceptual doses is referred to as microdosing.
- The medial prefrontal cortex (mPFC) is a key area of interest for understanding these effects.
- Epigenetic regulation in the mPFC is suggested to play a role in the therapeutic potential of psilocybin.
- Current knowledge on the molecular mechanisms involved remains limited.
Simplified
Psychedelic Science